an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis

Eyal Orion, MD, MBA

Founder and CEO

​​

Innovative solutions for improving the outcome of bypass surgery and quality-of-life for patients

VGS develops innovative solutions to improve the outcome of bypass surgery and quality-of-life for bypass patients.  

VEST™, the company’s first product, is an external stent used to support saphenous vein grafts, giving cardiologists a new type of bypass conduit that changes the CABG paradigm and improves its long-term clinical outcome.

​

FRAME™  external support in peripheral bypass and reconstruction procedures

VIOLA™ is a novel clampless proximal anastomosis system that allows surgeons to minimize aortic manipulations during proximal anastomosis suturing that can lead to neurologic complications.

The company has secured CE marking for VEST™,  FRAME™ and initiated marketing in Europe.